Ozempic and other diabetes weight loss drugs have soared in popularity in recent years, with more than 15 million adults in the U.S. taking a GLP-1 agonist. The drugs are designed to treat type 2 diabetes but successfully treat obesity, with the average…
[ad_2]
Source link
